Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive COVID-19 biobank aims to unlock secrets of severe disease

NCT ID NCT04318366

Knowledge-focused Sponsor: Università Vita-Salute San Raffaele Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is collecting medical information and biological samples from up to 6,000 people with COVID-19. Researchers want to find out which factors predict severe illness, death, or response to treatment. The goal is to better understand the disease and help guide future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 6,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2020

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

COVID-19 patients

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients admitted to hospital with biological samples positive for SARS-CoV-2 * Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease * Patients discharged from emergency department with biological samples positive for SARS-CoV-2 Exclusion Criteria: * None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronavirus infections are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease Coronaviridae infectious disease COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronavirus infections

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute

    RECRUITING

    Milan, Lombardy, 2012, Italy

  • Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Department of Internal Medicine - IRCCS San Raffaele Scientific Institute

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Diabetes Research Institute -IRCCS San Raffaele Scientific Istitute

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Division of Immunology, Transplantation and Infectious Diseases - IRCCS San Raffaele Scientific Institute

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Division of Research of Regenerative Medicine, Cell and Gene Therapy - IRCCS San Raffaele Scientific Istitute

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Laboratory of Microbiology and Virology - IRCCS San Raffaele Scientific Institute

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Nephrology Unit - IRCCS San Raffaele Scientific Institute

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Strategic Program in Nephrology and Dialysis - IRCCS San Raffaele Scientific Institute

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • Unit of Immunology, Rheumatology, Allergy and Rare Diseases - IRCCS San Raffaele Scientific Institute

    RECRUITING

    Milan, Lombardy, 2132, Italy

  • Università Vita-Salute San Raffaele

    RECRUITING

    Milan, Mi, 20132, Italy

  • Viral pathogens and biosafety Unit - IRCCS San Raffaele Scietific Institute

    RECRUITING

    Milan, Lombardy, 20132, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.